In addition, chemo- and radiotherapy, as well as growth factor receptor inhibitors targeting epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase-echinoderm microtubule-associated protein-like 4 fusion (ALK-EML), and neurotrophic tyrosine receptor kinase (NTRK), are extensively being used for the treatment of NSCLC, and these treatments also induce apoptosis. Here, ALK is linked to non-small cell lung carcinoma.